Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MustGrow Biologics ( (TSE:MGRO) ) just unveiled an announcement.
MustGrow Biologics has launched a non-brokered listed issuer financing exemption (LIFE) private placement of up to 4 million units at $0.50 per unit, aiming to raise as much as $2 million, with each unit comprising one common share and a five-year warrant exercisable at $0.70. The company plans to use the proceeds to ramp up inventory production of its TerraSante mustard-derived organic biofertility product, build inventory for agricultural products sold via its NexusBioAg distribution platform, and fund working capital, with the offering subject to TSX Venture Exchange approval and compliant insider participation rules under MI 61-101, signalling a push to scale commercialization and strengthen its position in the sustainable agri-inputs market.
The most recent analyst rating on (TSE:MGRO) stock is a Hold with a C$0.60 price target. To see the full list of analyst forecasts on MustGrow Biologics stock, see the TSE:MGRO Stock Forecast page.
Spark’s Take on TSE:MGRO Stock
According to Spark, TipRanks’ AI Analyst, TSE:MGRO is a Neutral.
The score is primarily held down by weak financial performance: large ongoing losses, sharp margin compression, and deeply negative operating/free cash flow despite revenue growth. Technical indicators are broadly neutral and do not materially offset the fundamental risk, while valuation is constrained by negative earnings and no dividend support.
To see Spark’s full report on TSE:MGRO stock, click here.
More about MustGrow Biologics
MustGrow Biologics Corp. is a Canadian agricultural biotechnology company focused on developing and commercializing mustard-derived organic crop inputs. Its product portfolio includes the TerraSante biofertility product and other biologically based agricultural solutions, which it distributes in part through its Canadian platform, NexusBioAg, targeting growers seeking sustainable and organic alternatives to conventional agrochemicals.
Average Trading Volume: 30,175
Technical Sentiment Signal: Sell
Current Market Cap: C$39.43M
See more data about MGRO stock on TipRanks’ Stock Analysis page.